Barclays Maintains Equal-Weight on Surgery Partners, Lowers Price Target to $18

Benzinga · 11/21/2025 17:41
Barclays analyst Andrew Mok maintains Surgery Partners (NASDAQ:SGRY) with a Equal-Weight and lowers the price target from $24 to $18.